BridgeBio Pharma Inc (BBIO)
25.23
-0.40
(-1.56%)
USD |
NASDAQ |
Oct 04, 16:00
25.24
+0.01
(+0.04%)
Pre-Market: 20:00
BridgeBio Pharma Shareholders Equity (Annual): -1.354B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.354B |
| December 31, 2022 | -1.255B |
| December 31, 2021 | -870.41M |
| December 31, 2020 | 57.91M |
| Date | Value |
|---|---|
| December 31, 2019 | 408.45M |
| December 31, 2018 | 314.88M |
| December 31, 2017 | -58.02M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-1.354B
Minimum
2023
408.45M
Maximum
2019
-602.59M
Average
-870.41M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Alnylam Pharmaceuticals Inc | -220.64M |
| Pfizer Inc | 89.01B |
| Vertex Pharmaceuticals Inc | 17.58B |
| PTC Therapeutics Inc | -818.56M |
| Bristol-Myers Squibb Co | 29.43B |